Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma

Citations

WEB OF SCIENCE

2
Citations

SCOPUS

2

초록

Purpose We performed this study to determine whether the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker of individual susceptibility to chemotherapeutic agents affecting treatment outcome in patients with neuroblastoma. Materials and Methods The study included 313 patients who received the first cycle chemotherapy with a CEDC (cisplatin+etoposi de+doxorubicin+cyclophosphamide) regimen and had absolute neutrophil count (ANC) data available. The cumulative incidences of progression and treatment-related mortality (TRM) were estimated. To identify genetic variations associated with the ANC, a genomewide association study (GWAS) was performed. Results An ANC of 32.5/mu L was determined as the cutoff point to categorize patients into the good and poor prognosis subgroups in terms of progression. Patients with a high nadir ANC had a higher cumulative incidence of progression than those with a low nadir ANC (p < 0.001). In multivariate analysis, high nadir ANC, age, bone marrow involvement, and unfavorable histology were poor prognostic factors. With regard to the TRM, patients with a low nadir ANC (ANC < 51.0/mu L) had a higher cumulative incidence of TRM than those with a high nadir ANC (p=0.010). In GWAS, single-nucleotide polymorphisms of LPHN2 and CRHR1 were significantly associated with the nadir ANC. Conclusion In neuroblastoma patients, the degree of neutropenia after the first chemotherapy cycle can be used as a surrogate marker to predict an individual's susceptibility to chemotherapeutic agents. Tailoring of treatment based on the degree of neutropenia needs to be considered.

키워드

&nbsp; Neuroblastoma; Neutropenia; Treatment outcome; Germline; Genome-wide association study; HIGH-RISK NEUROBLASTOMA; STEM-CELL TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; CANCER; ASSOCIATION; REGRESSION; CHILDREN
제목
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
저자
Lee, Ji Won; Bae, Joon Seol; Kim, Jin Ho; Cho, Hee Won; Ju, Hee Young; Yoo, Keon Hee; Koo, Hong Hoe; Woo, Sook-young; Kim, Seonwoo; Sung, Ki Woong
DOI
10.4143/crt.2021.010
발행일
2022-01
유형
Article
저널명
Cancer Research and Treatment
권
54
호
1
페이지
259 ~ 268